Device Trial Radar · NCT06150599
Sacral Neuromodulation for Chronic Pelvic Pain
Last checked: Nov 19, 2026Latest source record: Jul 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
25
Planned (sponsor's estimate)
Start
Jan 27, 2026
Primary completion
Apr 1, 2028
Study completion Dec 1, 2028
Sponsor
- Lead sponsor
- Corewell Health EastAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 29, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Female only, from 22 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Sacral neuromodulation (SNM) is a safe, effective, and minimally invasive FDA approved treatment for urinary and fecal incontinence, urinary frequency, urgency, and urinary retention. In this study we are assessing the effectiveness of sacral neuromodulation in women with suffering from chronic pelvic pain (CPP), through a single device implant procedure.
Conditions
- Chronic Pelvic Pain Syndrome
Interventions
Sacral neuromodulationDevice
Interstim X, which includes an implantable pulse generator and lead, will be implanted surgically in a single-stage procedure.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The change in pain score using a 10-point Visual Analogue Scale (VAS) from 2-10 weeks.Time frame: Visit 2 (2 weeks post-implant) and Visit 4 (10 weeks post-implant)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Corewell Health William Beaumont University Hospital
Royal Oak, Michigan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.